Numen Capital LLP Has $635,000 Position in Rite Aid Co. (RAD)
Numen Capital LLP increased its position in Rite Aid Co. (NYSE:RAD) by 150.0% in the 1st quarter, HoldingsChannel reports. The fund owned 1,000,000 shares of the company’s stock after buying an additional 600,000 shares during the quarter. Rite Aid makes up about 1.0% of Numen Capital LLP’s holdings, making the stock its 15th largest holding. Numen Capital LLP’s holdings in Rite Aid were worth $635,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Comerica Bank boosted its stake in Rite Aid by 12.9% in the 1st quarter. Comerica Bank now owns 73,784 shares of the company’s stock worth $42,000 after purchasing an additional 8,444 shares during the period. Paloma Partners Management Co boosted its stake in Rite Aid by 21.5% in the 4th quarter. Paloma Partners Management Co now owns 82,600 shares of the company’s stock worth $59,000 after purchasing an additional 14,600 shares during the period. Wedbush Securities Inc. boosted its stake in Rite Aid by 111.9% in the 4th quarter. Wedbush Securities Inc. now owns 37,875 shares of the company’s stock worth $27,000 after purchasing an additional 20,000 shares during the period. Brookstone Capital Management boosted its stake in Rite Aid by 111.8% in the 1st quarter. Brookstone Capital Management now owns 42,617 shares of the company’s stock worth $27,000 after purchasing an additional 22,500 shares during the period. Finally, Rhumbline Advisers boosted its stake in Rite Aid by 1.6% in the 1st quarter. Rhumbline Advisers now owns 1,586,561 shares of the company’s stock worth $1,007,000 after purchasing an additional 25,030 shares during the period.
RAD stock traded down $0.32 during midday trading on Wednesday, hitting $8.47. The company’s stock had a trading volume of 9,390 shares, compared to its average volume of 1,974,303. Rite Aid Co. has a 12 month low of $7.36 and a 12 month high of $42.40. The company has a debt-to-equity ratio of 2.93, a quick ratio of 0.91 and a current ratio of 1.68.
Several research analysts have weighed in on RAD shares. Zacks Investment Research downgraded Rite Aid from a “buy” rating to a “hold” rating in a research note on Tuesday, March 19th. Guggenheim restated a “sell” rating on shares of Rite Aid in a research note on Thursday, April 18th. Two analysts have rated the stock with a sell rating and five have given a hold rating to the company. The company has a consensus rating of “Hold” and an average price target of $38.33.
Rite Aid Profile
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Featured Article: Trading Strategy Methods for Individual Investors
Want to see what other hedge funds are holding RAD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rite Aid Co. (NYSE:RAD).
Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.